USANA Health Sciences Inc (USNA) is not a strong buy at this moment for a beginner investor with a long-term strategy. The financial performance shows declining profitability, and there are no significant positive trading signals or catalysts to justify immediate investment. A 'hold' action is recommended until better entry points or stronger growth signals emerge.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 50.152, and moving averages are converging, indicating no clear trend. Key resistance levels are at 22.194 and 23.126, while support levels are at 19.176 and 18.244.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

NULL significant. The news about Rise Wellness launching a new product is unrelated to USNA and does not directly impact the stock.

Neutral/Negative Catalysts

Declining financial performance in Q4 2025, with a significant drop in net income (-139.85%) and EPS (-143.48%). Gross margin also declined by 4.62%.

Financial Performance

In Q4 2025, revenue increased by 5.89% YoY to $226.2M, but net income dropped significantly to -$1.775M, and EPS fell to -0.1. Gross margin also decreased to 78.16%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

1 Analyst Rating

Wall Street analysts forecast USNA stock price to rise

0 Buy

1 Hold

0 Sell

Hold

Current: 21.520

Low

Averages

High